SCHEMBL21138744

SCHEMBL21138744

C=CCCC(C)(C)C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2440557 0.85 ALDH1A1 (0.40)
SCHEMBL3122938 0.81 TSHR (0.44)
SCHEMBL19969885 0.81 TSHR (0.44)
SCHEMBL8482041 0.77
SCHEMBL927451 0.77
SCHEMBL3629035 0.76
SCHEMBL6052846 0.75
SCHEMBL14323516 0.73 ALOX15 (0.52)
SCHEMBL29673032 0.72 ALDH1A1 (0.46)
SCHEMBL22639508 0.72 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025226861-A1 CYCLIN INHIBITORS CIRCLE PHARMA, INC. (US) 2025-10-30 WO disclosed
WO-2020221294-A1 BRIDGE RING-3,4-DIHYDRO-PYRIDO[1,2-A]PYRAZINE-1,8-DIONE COMPOUND AND PHARMACEUTICAL USE THEREOF 上海拓界生物医药科技有限公司 2020-11-05 WO disclosed
US-20190185479-A1 BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2019-06-20 US disclosed